G. Yanus

发表

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations

A. Sokolenko, E. Imyanitov, I. Bizin, 2022, Familial Cancer.

High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation.

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2015, Cancer letters.

Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele

A. Sokolenko, E. Imyanitov, A. Bessonov, 2014, Medical Oncology.

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas

E. Imyanitov, A. Iyevleva, S. Aleksakhina, 2023, International journal of molecular sciences.

Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women.

E. Imyanitov, E. Kuligina, T. Gorodnova, 2010, Cancer genetics and cytogenetics.

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I

E. Imyanitov, L. Demidov, A. Iyevleva, 2019, Case Reports in Oncology.

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1

E. Imyanitov, E. Kuligina, S. Aleksakhina, 2022, International journal of molecular sciences.

Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies

E. Imyanitov, A. Iyevleva, S. Aleksakhina, 2023, Sechenov Medical Journal.

Hereditary Renal Cancer Syndromes

E. Kuligina, G. Yanus, E. N. Imyanitov, 2024, Medical sciences.